Catalyst Wire Dossier Catalyst Wire Dossier

Bio Farma COVID-19 Protein Subunit Recombinant Vaccine

COVID-19 protein subunit recombinant vaccine · PT Bio Farma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bio Farma COVID-19 Protein Subunit Recombinant Vaccine, covering 2025-06-03 to 2025-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age [Phase 2]

See pricing